Albuterol Sulfate

Hyperkalemia, Acute Bronchitis, Pneumonia + 18 more

Treatment

9 FDA approvals

20 Active Studies for Albuterol Sulfate

What is Albuterol Sulfate

Salbutamol

The Generic name of this drug

Treatment Summary

Salbutamol is a medication used to treat asthma and COPD. It is 29 times more effective on the lungs than the heart, making it safer for pulmonary conditions. Salbutamol is a combination of two isomers, the R-isomer being 150 times more effective than the S-isomer. Levalbuterol, the single R-isomer of salbutamol, is more effective but more expensive than salbutamol. Salbutamol is usually used to treat sudden asthma attacks, chronic bronchitis, and COPD. It can also be used before exercise to prevent asthma symptoms.

Proair HFA

is the brand name

image of different drug pills on a surface

Albuterol Sulfate Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Proair HFA

Salbutamol

1981

314

Approved as Treatment by the FDA

Salbutamol, also known as Proair HFA, is approved by the FDA for 9 uses like Chronic Obstructive Pulmonary Disease and Bronchospasm, Exercise-Induced .

Chronic Obstructive Pulmonary Disease

Used to treat Chronic Obstructive Pulmonary Disease (COPD) in combination with Ipratropium

Bronchospasm, Exercise-Induced

Bronchial Spasm

prophylaxis of Exercise-induced bronchospasm

Bronchospasm

Bronchodilator Agents

Used to treat need of more than one bronchodilator in combination with Ipratropium

Asthma, Exercise-Induced

prophylaxis of Bronchospasm

Exercise-Induced Bronchospasm

Effectiveness

How Albuterol Sulfate Affects Patients

Salbutamol, also called albuterol, is a medicine used to relax airways and make it easier to breathe. It works by activating beta-1 and beta-2 receptors in the body. This causes the body to have a decreased blood pressure and relaxed muscles. It also may cause the body to produce more insulin and glucose. Taking salbutamol can lower potassium levels in the blood.

How Albuterol Sulfate works in the body

Salbutamol targets specific receptors in the airways and heart that cause the muscles to relax. It works by activating an enzyme, which increases the amount of a molecule called cyclic AMP. This molecule helps control the movement of ions in and out of cells, which reduces muscle tension. Salbutamol also prevents the release of mediators from cells in the airway, blocking the effects of irritants. When taken as medication, salbutamol usually starts to work within 5-15 minutes, and its effects can last for up to 6 hours.

When to interrupt dosage

The measure of Albuterol Sulfate is contingent upon the diagnosed affliction, including Bronchodilator Agents, Emphysema and Wheezing. The volume of dosage fluctuates per the technique of delivery featured in the table beneath.

Condition

Dosage

Administration

prophylaxis of Bronchospasm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Bronchitis, Chronic

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Acute Bronchitis

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Respiratory Tract Infections

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Influenza

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Bronchodilation

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Bronchial Spasm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Emphysema

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Asthma, Exercise-Induced

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Pneumonia

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Bronchitis

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Airway secretion clearance therapy

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

excess mucus or phlegm

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Hyperkalemia

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Asthma

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Respiratory Sounds

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Chronic Obstructive Pulmonary Disease

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Bronchospasm, Exercise-Induced

2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation

, Oral, Syrup, Syrup - Oral, Solution - Respiratory (inhalation), Respiratory (inhalation), Solution, Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet, Tablet - Oral, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Intramuscular, Liquid - Intramuscular, Capsule - Respiratory (inhalation), Capsule, Solution - Intramuscular, Powder, metered, Powder, metered - Respiratory (inhalation), Spray, metered - Respiratory (inhalation), Inhalant - Respiratory (inhalation), Inhalant, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal, Spray, Spray - Oral, Spray, metered, Liquid - Intravenous, Solution - Oral, Liquid - Oral, Aerosol, spray - Oral, Aerosol, spray

Warnings

There are 20 known major drug interactions with Albuterol Sulfate.

Common Albuterol Sulfate Drug Interactions

Drug Name

Risk Level

Description

Hydroxyzine

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Hydroxyzine.

Mobocertinib

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Mobocertinib.

Ziprasidone

Major

The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ziprasidone.

1-benzylimidazole

Minor

The risk or severity of hypertension can be increased when Salbutamol is combined with 1-benzylimidazole.

2,5-Dimethoxy-4-ethylamphetamine

Minor

The risk or severity of hypertension can be increased when Salbutamol is combined with 2,5-Dimethoxy-4-ethylamphetamine.

Albuterol Sulfate Toxicity & Overdose Risk

Taking too much albuterol can lead to symptoms like rapid heartbeat, high or low blood pressure, shaking, headache, dry mouth, nausea, fatigue, insomnia, high blood sugar, low potassium, and acid buildup in the blood. Albuterol can also be dangerous for pregnant women and their babies. It should not be used by nursing mothers or in children under 4 years of age. Elderly people should take smaller doses of albuterol as they may be more sensitive to its effects. The most toxic dose of albuterol was found to be 1100mg/kg in mice.

image of a doctor in a lab doing drug, clinical research

Albuterol Sulfate Novel Uses: Which Conditions Have a Clinical Trial Featuring Albuterol Sulfate?

Condition

Clinical Trials

Trial Phases

prophylaxis of Bronchospasm

0 Actively Recruiting

Influenza

28 Actively Recruiting

Not Applicable, Phase 3, Phase 4, Phase 2, Phase 1

Asthma

97 Actively Recruiting

Phase 1, Phase 4, Not Applicable, Early Phase 1, Phase 2, Phase 3

Chronic Obstructive Pulmonary Disease

77 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3, Phase 4

Bronchospasm, Exercise-Induced

0 Actively Recruiting

Hyperkalemia

4 Actively Recruiting

Phase 3, Phase 2, Phase 1, Not Applicable

Bronchitis, Chronic

6 Actively Recruiting

Phase 2, Not Applicable, Phase 4

excess mucus or phlegm

0 Actively Recruiting

Bronchodilator Agents

0 Actively Recruiting

Pneumonia

18 Actively Recruiting

Not Applicable, Phase 2, Early Phase 1, Phase 4

Bronchial Spasm

0 Actively Recruiting

Asthma

10 Actively Recruiting

Phase 2, Not Applicable

Airway secretion clearance therapy

0 Actively Recruiting

Respiratory Sounds

0 Actively Recruiting

Asthma

1 Actively Recruiting

Phase 4

Asthma, Exercise-Induced

0 Actively Recruiting

Emphysema

6 Actively Recruiting

Phase 2, Not Applicable, Early Phase 1

Bronchitis

0 Actively Recruiting

Acute Bronchitis

6 Actively Recruiting

Not Applicable, Phase 3, Early Phase 1, Phase 4

Bronchodilation

0 Actively Recruiting

Albuterol Sulfate Reviews: What are patients saying about Albuterol Sulfate?

5

Patient Review

5/20/2014

Albuterol Sulfate for Asthma Prevention

This medication worked great for my pneumonia. The only downside was that I got really bad shakes after taking it, but they only lasted half an hour before I fell asleep for four hours.

5

Patient Review

12/3/2014

Albuterol Sulfate for Bronchitis

I'm curious about how much sulfate is in this medication.

4.7

Patient Review

10/28/2014

Albuterol Sulfate for Obstructive Pulmonary Disease

Albuterol is very effective for me in terms of managing my shortness of breath. I have to be careful not to wait too long before using it, or else it becomes much harder to get my breathing under control.

4.3

Patient Review

5/24/2010

Albuterol Sulfate for Obstructive Pulmonary Disease

This didn't help me as much as I'd hoped.

4

Patient Review

2/11/2013

Albuterol Sulfate for Asthma

We're using this on our three-month-old son. He's been shaking every five minutes and screaming when the spasms hit. The doctors say it's normal, but it only seems to help his breathing for a short while. He can't sleep and recover that way.

4

Patient Review

1/14/2012

Albuterol Sulfate for Obstructive Pulmonary Disease

This medication helps with my wheezing and breathing difficulties, but the drowsiness it induces is really intense. I only take it when needed, and even then I make sure to rest afterwards. It's not a perfect solution, but it does allow me to function relatively normally.

4

Patient Review

9/15/2016

Albuterol Sulfate for Asthma

Having asthma at 18 isn't fun, but this drug usually helps me out. The main downside is that I have to sit in one spot for 15 minutes, and it also makes me shaky and nervous for a while. But overall it does help me breathe better.

3.7

Patient Review

8/25/2011

Albuterol Sulfate for Asthma

I was instructed by ER doctors to give this to my almost 4 year old daughter. I have given her 3 dosages and she looks lethargic, has thrown up so many times I can not count, refuses to eat anything, scared, complains her legs hurt, and I will not be giving this to her again.

3.7

Patient Review

12/23/2014

Albuterol Sulfate for Bronchitis

My son has had RSV since he was 4 months old and it's led to a number of issues with his lungs, including bronchitis. We've used this medication every time he's had problems and have never experienced any side effects.

2.3

Patient Review

1/19/2013

Albuterol Sulfate for Bronchitis

I have lower severe lower back pain does not hurt when I urinate but after I do back pain subside's a little. This treatment wasn't as effective as I hoped.

2

Patient Review

12/26/2013

Albuterol Sulfate for Obstructive Pulmonary Disease

This treatment didn't do much for me in terms of reducing the redness on my face.

2

Patient Review

8/31/2013

Albuterol Sulfate for Emphysema

I decided to take my 6-month-old's bronchitis medicine for myself, and I was immediately sorry. I started shaking uncontrollably, my heart rate skyrocketed, and I started getting hot and coughing until I vomited.

1.7

Patient Review

3/31/2010

Albuterol Sulfate for Asthma

1.3

Patient Review

3/25/2011

Albuterol Sulfate for Bronchospasm

I tried this medication for Mannose Binding Lectin Deficiency, but it didn't help me at all.

1

Patient Review

3/16/2013

Albuterol Sulfate for Bronchitis

While this treatment is effective, it can be a bit of a hassle to use. I recommend finding a fast-acting inhaler instead.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about albuterol sulfate

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How often should you use albuterol sulfate?

"Adults and children 4 years and older should take two puffs every 4 to 6 hours as needed."

Answered by AI

What is Albuterol Sulfate medicine used for?

"Albuterol is used to manage difficulty breathing, wheezing, shortness of breath, coughing, and chest tightness caused by lung diseases, such as asthma and COPD."

Answered by AI

What are side effects of albuterol?

"The side effects of albuterol can include feeling nervous or shaky, having a headache, feeling like your heart is pounding, or having muscle aches. Less serious but more common side effects include a rapid heart rate or feeling like your heart is fluttering."

Answered by AI

Is albuterol sulfate a steroid?

"Albuterol is not a steroid. Rather, it is a beta-agonist, a type of drug that works by attaching to beta-receptors in the airways. This relaxes the muscles in the airways, making it easier for the person to breathe."

Answered by AI

Clinical Trials for Albuterol Sulfate

Image of Allergy and Clinical Immunology Associates in Pittsburgh, United States.

Tilrekimig for Asthma

12 - 80
All Sexes
Pittsburgh, PA

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. Tilrekimig or the placebo will be given about every 4 weeks during the study. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.

Phase 3
Recruiting

Allergy and Clinical Immunology Associates (+2 Sites)

Pfizer CT.gov Call Center

Pfizer

Image of Seattle Children's Hospital in Seattle, United States.

Follow-Up Strategies for Children With Medical Complexity

1 - 16
All Sexes
Seattle, WA

Children with medical complexity often receive a recommendation to see an outpatient clinician soon after leaving the hospital. It is uncertain whether every child needs this routine visit or whether follow-up can be guided by the family's concerns and the child's recovery. AFTERCARE is a multicenter pilot randomized trial comparing these two follow-up recommendations for children hospitalized with an acute infection. Families will be assigned by chance to receive either a recommendation to arrange follow-up with their usual outpatient clinician within seven days or a recommendation to seek follow-up if the child is not improving as expected or new concerns arise. Families in both groups may seek medical care whenever needed. The study will assess recruitment, follow-up data collection, delivery of the recommendations and acceptability. Caregiver surveys and medical record review will also describe outpatient visits and hospital returns. This pilot will inform the design of a larger trial, and is not designed to establish that the strategies are equally safe or effective.

Waitlist Available
Has No Placebo

Seattle Children's Hospital

Nassr Nama, MD, MSc

Have you considered Albuterol Sulfate clinical trials?

We made a collection of clinical trials featuring Albuterol Sulfate, we think they might fit your search criteria.
Go to Trials
Image of Rocky Mountain Regional VA Medical Center, Aurora, CO in Aurora, United States.

Low-Dose CT for Lung Cancer Screening

50 - 80
All Sexes
Aurora, CO

Lung cancer screening with low-dose chest computed tomography (CT) is currently recommended for high-risk individuals who are 50 to 80 years old, have smoked cigarettes for at least 20 pack-years, and currently smoke or quit smoking within the past 15 years. In a prospective cohort at Nashville, Denver, Louisville, Chicago, Kansas City, Salisbury and Seattle Veteran Affairs medical centers, the investigators will evaluate the detection of lung cancer using an expanded screening eligibility criteria based on Veterans' personal and service-related exposures compared to standard of care criteria. Screening a larger population will increase the number of lung nodules needing clinical management and these nodules may or may not be cancer. In a population of Veterans with positive screenings at Nashville, the investigators will also validate a combination biomarker-based approach to manage screen-detected lung nodules to reduce time to lung cancer diagnosis and use of invasive procedures. This study will also convene a Veteran Community Advisory Board and interview Veterans to better understand their thoughts about lung cancer screening and preferences for outreach and engagement.

Waitlist Available
Has No Placebo

Rocky Mountain Regional VA Medical Center, Aurora, CO (+6 Sites)

Jennifer A Lewis, MD MS MPH

Bristol-Myers Squibb

Image of Emory University Hospital (EUH) in Atlanta, United States.

Influenza Transmission Study

18 - 49
All Sexes
Atlanta, GA

The purpose of this study is to determine whether influenza A or B can be transmitted from adults with naturally acquired community influenza infection to healthy adult recipients under controlled inpatient exposure conditions, and to identify donor, recipient, viral, immunologic, behavioral, and environmental factors associated with transmission. This study differs from a traditional influenza CHIM because no challenge stock will be administered. Instead, naturally infected community donors will serve as the source of exposure. This approach is intended to better reflect naturally circulating influenza viruses and naturally infected donors while preserving the safety advantages of inpatient monitoring, defined exposure windows, controlled environmental measurements, and standardized sampling.

Waitlist Available
Has No Placebo

Emory University Hospital (EUH) (+1 Sites)

Nadine Rouphael, MD, MSc

Have you considered Albuterol Sulfate clinical trials?

We made a collection of clinical trials featuring Albuterol Sulfate, we think they might fit your search criteria.
Go to Trials
Image of SMS Clinical Research LLC in Garland, United States.

Tilrekimig for Severe Asthma

12 - 80
All Sexes
Garland, TX

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called tilrekimig) for the potential treatment of severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life of people who are affected. The study is seeking participants who: * Have a history of severe asthma for at least 12 months * Have had at least 2 asthma attacks (also known as exacerbations) within the last 12 months All participants will be given shots of study medicine or a placebo at the study clinic. The study will compare the experiences of people receiving tilrekimig to those people who receive the placebo. This will help determine if tilrekimig is safe and effective.

Phase 3
Recruiting

SMS Clinical Research LLC (+6 Sites)

Pfizer CT.gov Call Center

Pfizer

Image of St. Michael's Hospital (Unity Health Toronto) in Toronto, Canada.

Treatment for Hyperkalemia

18+
All Sexes
Toronto, Canada

People with end-stage kidney disease who receive hemodialysis are often told to strictly limit foods high in potassium, such as fruits, vegetables, legumes, nuts, and whole grains. This advice is intended to prevent high blood potassium levels (hyperkalemia), which can cause dangerous heart rhythm problems. However, these restrictions can make eating difficult, reduce diet quality, and lower quality of life. New research suggests that not all sources of potassium affect the body in the same way. Potassium added to highly processed foods is more easily absorbed than potassium naturally found in whole foods like fruits and vegetables. Large studies have found little evidence that eating potassium-rich whole foods increases blood potassium levels in people on dialysis. Clinical guidelines are beginning to shift, but no high-quality clinical trial has tested whether a more flexible, food-based approach is safe for people receiving hemodialysis. This study will compare two dietary approaches in 148 adults on hemodialysis: the usual low potassium diet and a "liberalized" potassium diet that encourages minimally processed foods while limiting highly processed foods with potassium additives. Participants will receive dietitian support and grocery assistance for 12 weeks. The investigators will closely monitor blood potassium levels to ensure safety. The investigators will also examine whether the liberalized diet is as safe as standard care, and whether it improves diet quality and quality of life. The investigators will also study factors that influence the participant's ability to follow the diet in real-world settings. If safe, this approach could reduce unnecessary food restrictions, improve diet quality, and enhance quality of life for people receiving hemodialysis, while maintaining patient safety.

Waitlist Available
Has No Placebo

St. Michael's Hospital (Unity Health Toronto)

JoAnne Arcand, PhD, RD

Have you considered Albuterol Sulfate clinical trials?

We made a collection of clinical trials featuring Albuterol Sulfate, we think they might fit your search criteria.
Go to Trials